Fig. 2
Kaplan–Meier analyses of progression-free survival according to A α-fetoprotein levels, B tumor size, C regorafenib dose, and D best response
Fig. 2 | BMC Gastroenterology
Kaplan–Meier analyses of progression-free survival according to A α-fetoprotein levels, B tumor size, C regorafenib dose, and D best response